Perennial Investment Advisors LLC trimmed its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 5.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,247 shares of the medical device company’s stock after selling 175 shares during the […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) – Zacks Research lowered their Q2 2023 EPS estimates for DexCom in a research note issued on Thursday, May 11th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical device company will post earnings per share of $0.20 for the quarter, down from their previous estimate of $0.21. […]
DexCom, Inc. (NASDAQ:DXCM – Get Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 12,730,000 shares, an increase of 5.4% from the April 15th total of 12,080,000 shares. Based on an average trading volume of 2,350,000 shares, the short-interest ratio is presently […]
Huntington National Bank grew its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 32.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 592 shares of the medical device company’s stock after purchasing an additional 144 shares during […]
Brown Brothers Harriman & Co. increased its holdings in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 145.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,973 shares of the medical device company’s stock after acquiring an additional 2,944 shares […]